Halozyme COVID-19 Response

To Our Shareholders: 2019 Year in Review
Homepage

Science

ENHANZE® Technology

HYLENEX® recombinant

(hyaluronidase human injection)

Careers

Investors

About Us

Useful Links

Contact Info


Office:

Halozyme
11388 Sorrento Valley Road
San Diego, CA 92121
Phone: 858.794.8889
info@halozyme.com

Recent News

October 22, 2020 Halozyme To Host Third Quarter 2020 Financial Results Webcast and Conference Call
October 6, 2020 Halozyme Announces Expansion Of Collaboration And License Agreement With argenx For ENHANZE® Technology
September 17, 2020 Halozyme Announces Poster Presentation Of Data From Roche's Phase 1b Study Evaluating Atezolizumab For Subcutaneous Administration Utilizing Enhanze® In Non-Small Cell Lung Cancer
Copyright© 2015-2019. Halozyme, Inc. All rights reserved. All trademarks belong to their respective owners.
Powered By Q4 Inc. 5.45.1.1

Notice

You are now leaving Halozyme.com. Halozyme is not responsible for or endorses the content of the linked site.

Ok